Sfoglia per Autore
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience
2007-01-01 Costanzo, A; Peris, K; Talamonti, M; Di Cesare, A; Fargnoli, Mc; Botti, E; Chimenti, S
Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv)
2008-01-01 Botti, E; Hundhausen, C; Laggner, U; DI MEGLIO, P; Marget, M; Chimenti, S; Nestle, Fo
Investigating the expression of the susceptibility allele HLA-Cw6 in psoriasis using a specific single chain fragment antibody
2008-01-01 Botti, E; Hundhausen, C; Laggner, U; Mazzotta, A; DI MEGLIO, P; Marget, M; Chimenti, S; Nestle, Fo
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway
2008-01-01 Marinari, B; Moretti, F; Botti, E; Giustizieri, Ml; Descargues, P; Giunta, A; Stolfi, C; Ballaro, C; Papoutsaki, M; Alema, S; Monteleone, G; Chimenti, S; Karin, M; Costanzo, A
IL-21, a new player in pathogenesis of psoriasis
2009-01-01 Botti, E; Caruso, R; Sarra, M; Laura, D; Pallone, F; Chimenti, S; Monteleone, G; Costanzo, A
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis
2009-01-01 Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers
2009-01-01 Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis
2009-01-01 Caruso, R; Botti, E; Sarra, M; Esposito, M; Stolfi, C; Diluvio, L; Giustizieri, M; Pacciani, V; Mazzotta, A; Campione, E; Macdonald, T; Chimenti, S; Pallone, F; Costanzo, A; Monteleone, G
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy
2009-01-01 Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias
2010-05-03 Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson Lindahl, E; Merlo, G; Mills, A; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A
IL-21 in the pathogenesis and treatment of skin diseases
2010-11-01 Costanzo, A; Chimenti, Ms; Botti, E; Caruso, R; Sarra, M; Monteleone, G
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia
2011-01-01 Sarra, M; Caruso, R; Cupi, M; Monteleone, I; Stolfi, C; Costanzo, A; Campione, E; Pallone, F; Diluvio, L; Mazzotta, A; Botti, E; Chimenti, S; Costanzo, A; Macdonald, T; Pallone, F; Monteleone, G
Patients with moderate to severe plaque psoriasis: One year after the European medicines agency recommendation of efalizumab suspension
2011-01-01 Talamonti, M; Teoli, M; Botti, E; Spallone, G; Chimenti, S; Costanzo, A
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas
2011-01-01 Botti, E; Spallone, G; Moretti, F; Marinari, B; Pinetti, V; Galanti, S; De Meo, Pd; De Nicola, F; Ganci, F; Castrignano, T; Pesole, G; Chimenti, S; Guerrini, L; Fanciulli, M; Blandino, G; Karin, M; Costanzo, A
Targeted therapy in nonmelanoma skin cancers
2011-01-01 Spallone, G; Botti, E; Costanzo, A
Confocal, wide band spectral reflection microscope, and relevant spectral imaging method
2011-12-01 Romana Bertani, F; Botti, E; Cilloco, F; Costanzo, A; Ferrari, L; Selci, S
Nanomedicine in dermatology: Benefits and emerging applications
2012-01-01 Saraceno, R; Chiricozzi, A; Botti, E; Gramiccia, T; Pietroleonardo, L; Chimenti, S
TRIM8 and p53: Making the right decision
2012-01-01 Botti, E; Spallone, G; Costanzo, A
Allele-specific cytokine responses at the HLA-C locus: Implications for psoriasis
2012-01-01 Hundhausen, C; Bertoni, A; Mak, Rk; Botti, E; Di Meglio, P; Clop, A; Laggner, U; Chimenti, S; Hayday, Ac; Barker, Jn; Trembath, Rc; Capon, F; Nestle, Fo
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target
2012-08-01 Botti, E; Spallone, G; Caruso, R; Monteleone, G; Chimenti, S; Costanzo, A
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2007 | Long-term treatment of plaque psoriasis with efalizumab: an Italian experience | Costanzo, A; Peris, K; Talamonti, M; Di Cesare, A; Fargnoli, Mc; Botti, E; Chimenti, S | Articolo su rivista | |
1-gen-2008 | Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv) | Botti, E; Hundhausen, C; Laggner, U; DI MEGLIO, P; Marget, M; Chimenti, S; Nestle, Fo | Intervento a convegno | |
1-gen-2008 | Investigating the expression of the susceptibility allele HLA-Cw6 in psoriasis using a specific single chain fragment antibody | Botti, E; Hundhausen, C; Laggner, U; Mazzotta, A; DI MEGLIO, P; Marget, M; Chimenti, S; Nestle, Fo | Intervento a convegno | |
1-gen-2008 | The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway | Marinari, B; Moretti, F; Botti, E; Giustizieri, Ml; Descargues, P; Giunta, A; Stolfi, C; Ballaro, C; Papoutsaki, M; Alema, S; Monteleone, G; Chimenti, S; Karin, M; Costanzo, A | Articolo su rivista | |
1-gen-2009 | IL-21, a new player in pathogenesis of psoriasis | Botti, E; Caruso, R; Sarra, M; Laura, D; Pallone, F; Chimenti, S; Monteleone, G; Costanzo, A | Intervento a convegno | |
1-gen-2009 | HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis | Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S | Intervento a convegno | |
1-gen-2009 | Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers | Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S | Articolo su rivista | |
1-gen-2009 | Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis | Caruso, R; Botti, E; Sarra, M; Esposito, M; Stolfi, C; Diluvio, L; Giustizieri, M; Pacciani, V; Mazzotta, A; Campione, E; Macdonald, T; Chimenti, S; Pallone, F; Costanzo, A; Monteleone, G | Articolo su rivista | |
1-gen-2009 | Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy | Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S | Articolo su rivista | |
3-mag-2010 | A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias | Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson Lindahl, E; Merlo, G; Mills, A; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A | Articolo su rivista | |
1-nov-2010 | IL-21 in the pathogenesis and treatment of skin diseases | Costanzo, A; Chimenti, Ms; Botti, E; Caruso, R; Sarra, M; Monteleone, G | Articolo su rivista | |
1-gen-2011 | IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia | Sarra, M; Caruso, R; Cupi, M; Monteleone, I; Stolfi, C; Costanzo, A; Campione, E; Pallone, F; Diluvio, L; Mazzotta, A; Botti, E; Chimenti, S; Costanzo, A; Macdonald, T; Pallone, F; Monteleone, G | Articolo su rivista | |
1-gen-2011 | Patients with moderate to severe plaque psoriasis: One year after the European medicines agency recommendation of efalizumab suspension | Talamonti, M; Teoli, M; Botti, E; Spallone, G; Chimenti, S; Costanzo, A | Articolo su rivista | |
1-gen-2011 | Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas | Botti, E; Spallone, G; Moretti, F; Marinari, B; Pinetti, V; Galanti, S; De Meo, Pd; De Nicola, F; Ganci, F; Castrignano, T; Pesole, G; Chimenti, S; Guerrini, L; Fanciulli, M; Blandino, G; Karin, M; Costanzo, A | Articolo su rivista | |
1-gen-2011 | Targeted therapy in nonmelanoma skin cancers | Spallone, G; Botti, E; Costanzo, A | Articolo su rivista | |
1-dic-2011 | Confocal, wide band spectral reflection microscope, and relevant spectral imaging method | Romana Bertani, F; Botti, E; Cilloco, F; Costanzo, A; Ferrari, L; Selci, S | Brevetti | |
1-gen-2012 | Nanomedicine in dermatology: Benefits and emerging applications | Saraceno, R; Chiricozzi, A; Botti, E; Gramiccia, T; Pietroleonardo, L; Chimenti, S | Contributo in libro | |
1-gen-2012 | TRIM8 and p53: Making the right decision | Botti, E; Spallone, G; Costanzo, A | Articolo su rivista | |
1-gen-2012 | Allele-specific cytokine responses at the HLA-C locus: Implications for psoriasis | Hundhausen, C; Bertoni, A; Mak, Rk; Botti, E; Di Meglio, P; Clop, A; Laggner, U; Chimenti, S; Hayday, Ac; Barker, Jn; Trembath, Rc; Capon, F; Nestle, Fo | Articolo su rivista | |
1-ago-2012 | Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target | Botti, E; Spallone, G; Caruso, R; Monteleone, G; Chimenti, S; Costanzo, A | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile